FR EN
Share this page

Delphine BADINAND

MD

    Onco-radiotherapist at the Timone Hospital

APHM

MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

#clinique 

Have a look on our testimonies

MI COMMUNITY
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM
MI COMMUNITY
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.

Norbert VEY
AMU, IPC
MI COMMUNITY
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients

Emmanuelle CHARAFE-JAUFFRET
AMU, IPC, CRCM
MI COMMUNITY
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.

Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA
MI AND YOU Show
your commitment to MI